A complex proinflammatory cascade mediates the activation of HSCs upon LPS exposure in vivo.
Journal
Blood advances
ISSN: 2473-9537
Titre abrégé: Blood Adv
Pays: United States
ID NLM: 101698425
Informations de publication
Date de publication:
14 06 2022
14 06 2022
Historique:
received:
03
09
2021
accepted:
13
03
2022
pubmed:
13
4
2022
medline:
15
6
2022
entrez:
12
4
2022
Statut:
ppublish
Résumé
Infections are a key source of stress to the hematopoietic system. While infections consume short-lived innate immune cells, their recovery depends on quiescent hematopoietic stem cells (HSCs) with long-term self-renewal capacity. Both chronic inflammatory stress and bacterial infections compromise competitive HSC capacity and cause bone marrow (BM) failure. However, our understanding of how HSCs act during acute and contained infections remains incomplete. Here, we used advanced chimeric and genetic mouse models in combination with pharmacological interventions to dissect the complex nature of the acute systemic response of HSCs to lipopolysaccharide (LPS), a well-established model for inducing inflammatory stress. Acute LPS challenge transiently induced proliferation of quiescent HSCs in vivo. This response was not only mediated via direct LPS-TLR4 conjugation on HSCs but also involved indirect TLR4 signaling in CD115+ monocytic cells, inducing a complex proinflammatory cytokine cascade in BM. Downstream of LPS-TLR4 signaling, the combined action of proinflammatory cytokines such as interferon (IFN)α, IFNγ, tumor necrosis factor-α, interleukin (IL)-1α, IL-1β, and many others is required to mediate full HSC activation in vivo. Together, our study reveals detailed mechanistic insights into the interplay of proinflammatory cytokine-induced molecular pathways and cell types that jointly orchestrate the complex process of emergency hematopoiesis and HSC activation upon LPS exposure in vivo.
Identifiants
pubmed: 35413096
pii: 484881
doi: 10.1182/bloodadvances.2021006088
pmc: PMC9198917
doi:
Substances chimiques
Cytokines
0
Lipopolysaccharides
0
Toll-Like Receptor 4
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
3513-3528Informations de copyright
© 2022 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.
Références
J Immunol. 2011 May 1;186(9):5367-75
pubmed: 21441445
Curr Opin Hematol. 2016 Jan;23(1):5-10
pubmed: 26554891
J Immunol. 1997 Oct 1;159(7):3364-71
pubmed: 9317135
Cell. 2007 Nov 30;131(5):994-1008
pubmed: 18045540
Cell Stem Cell. 2017 Aug 3;21(2):225-240.e5
pubmed: 28736216
Trends Biotechnol. 1997 May;15(5):178-85
pubmed: 9161052
Blood. 2019 Oct 17;134(16):1312-1322
pubmed: 31387916
Front Immunol. 2020 Nov 24;11:585367
pubmed: 33329562
Immunity. 2006 Jun;24(6):801-812
pubmed: 16782035
J Immunol. 2001 Nov 15;167(10):5887-94
pubmed: 11698465
Nature. 2010 Jun 10;465(7299):793-7
pubmed: 20535209
Exp Hematol. 2019 Dec;80:36-41.e3
pubmed: 31812712
Cytokine Growth Factor Rev. 2008 Feb;19(1):3-19
pubmed: 18248767
Nat Rev Immunol. 2014 May;14(5):302-14
pubmed: 24751955
Science. 1998 Dec 11;282(5396):2085-8
pubmed: 9851930
J Exp Med. 2011 Feb 14;208(2):261-71
pubmed: 21282381
J Clin Oncol. 2011 Jul 20;29(21):2897-903
pubmed: 21690473
Front Immunol. 2016 Nov 14;7:502
pubmed: 27895645
Science. 2003 Aug 1;301(5633):640-3
pubmed: 12855817
Cell Death Differ. 2003 Jan;10(1):45-65
pubmed: 12655295
Nat Rev Immunol. 2011 Oct 10;11(11):762-74
pubmed: 21984070
Blood. 2014 Aug 28;124(9):1393-403
pubmed: 24990886
Clin Microbiol Rev. 2009 Apr;22(2):240-73, Table of Contents
pubmed: 19366914
Annu Rev Immunol. 2003;21:335-76
pubmed: 12524386
Blood. 2003 Feb 1;101(3):1155-63
pubmed: 12393599
Cell. 2010 Mar 19;140(6):805-20
pubmed: 20303872
Cell. 2008 Dec 12;135(6):1118-29
pubmed: 19062086
Nat Rev Immunol. 2007 May;7(5):353-64
pubmed: 17457343
Nature. 2009 Apr 16;458(7240):904-8
pubmed: 19212321
J Exp Med. 2014 Feb 10;211(2):245-62
pubmed: 24493802
Nat Med. 2005 Nov;11(11):1180-7
pubmed: 16208318
Haematologica. 2010 Jul;95(7):1216-20
pubmed: 20053870
J Clin Invest. 2010 Nov;120(11):4091-101
pubmed: 20972332
Blood. 2003 Jan 15;101(2):517-23
pubmed: 12393491
J Immunol. 1998 Jan 15;160(2):943-52
pubmed: 9551933
Immunity. 1998 Jul;9(1):143-50
pubmed: 9697844
Stem Cells. 2012 Jul;30(7):1486-95
pubmed: 22511319
J Immunol. 2015 Sep 15;195(6):2524-8
pubmed: 26276875
Exp Hematol. 2021 Apr;96:1-12
pubmed: 33571568
Nat Rev Immunol. 2010 Mar;10(3):201-9
pubmed: 20182459
Front Immunol. 2016 Sep 16;7:362
pubmed: 27695456
Blood. 2012 Mar 29;119(13):2991-3002
pubmed: 22246037
Science. 1993 Mar 19;259(5102):1742-5
pubmed: 8456301
Science. 1994 Jun 24;264(5167):1918-21
pubmed: 8009221
Cell Rep. 2017 Jun 13;19(11):2345-2356
pubmed: 28614719
Nature. 2015 Apr 23;520(7548):549-52
pubmed: 25707806
Annu Rev Immunol. 2009;27:669-92
pubmed: 19132917
J Innate Immun. 2017;9(5):464-474
pubmed: 28641299